111897-21-3

Basic information

• Product Name: dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylic acid
• CAS NO: 111897-21-3
• Molecular Weight: 390.303
• Mol File: 111897-21-3.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylic acid(111897-21-3)
• EPA Substance Registry System: dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylic acid(111897-21-3)

Safety Data

• Hazardous Substances Data: 111897-21-3(Hazardous Substances Data)

Upstream product

• 81474-46-6 4-bromo-7-methoxybenzo[1,3]dioxole-5-carboxylic acid methyl ester 
• 111897-19-9 DDB 
• 123685-25-6 5-methoxy-3,4-dihydroxy-2-bromobenzoic acid methyl ester 
• 143883-73-2 2-bromo-5-O-methyl gallic acid 
• 149-91-7 3,4,5-trihydroxybenzoic acid 
• 3934-84-7 3,4-dihydroxy-5-methoxybenzoic acid 

Downstream Products

• 205117-47-1 7,7'-dimethoxy-5'-(methoxycarbonyl)-4,4'-bibenzo[d][1,3]dioxole-5-carboxylic acid 
• 1372720-37-0 (E)-methyl 5'-(3-(2,5-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-36-9 (E)-methyl 5'-(3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)-7,7'-dimethoxy-{4,4'-bibenzo[d][1,3]dioxole}-5-carboxylate 
• 1372720-35-8 (E)-methyl 7,7'-dimethoxy-5'-(3-(2-methoxyphenyl)-3-oxoprop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-34-7 (E)-methyl 7,7'-dimethoxy-5'-(3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-33-6 (E)-5'-(3-(4-hydroxy)phenyl-3-oxo-1-propenyl)-7,7'-dimethoxy-4,4'-dibenzo[d] [1,3]dioxol-5-carboxylic acid methyl ester 
• 1372720-32-5 (E)-methyl 7,7'-dimethoxy-5'-(3-oxo-3-phenylprop-1-en-1-yl)-{4,4'-bibenzo[d][1,3]dioxole}-5-carboxylate 
• 1372720-43-8 (E)-methyl 5'-(2-cyano-3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-42-7 (E)-methyl 5'-(2-cyano-3-oxo-3-(p-tolyl)prop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-41-6 (E)-methyl 5'-(2-cyano-3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-40-5 (E)-methyl 7,7'-dimethoxy-5'-(3-(4-nitrophenyl)-3-oxoprop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-39-2 (E)-methyl 7,7'-dimethoxy-5'-(3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 118159-48-1 bicyclol 

Relevant articles and documents

Synthesis and antihepatotoxicity of some Wuweizisu analogues

A preparation of dimethyl 4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate (VII) was readily achieved. It provided the advantages of specificity, simplicity, and efficiency in reactions. 6-Phenyl-3,9-dimethoxy-1,2-methylenedioxy-10,11-methylenedioxy-6,7- dihydro-5H-dibenz(c, e)azepin (X) was successfully synthesized from VII (DDB) and its liver-protective property proved to be more effective than DDB and silymarin in the in vitro test of carbon tetrachloride-induced damage of primary cultured rat hepatocytes.

Alkoxybiphenyl alpha, beta-unsaturated amide compound and preparing method and medical application thereof

The invention relates to an alkoxybiphenyl alpha, beta-unsaturated amide compound and a preparing method and medical application thereof, and belongs to the fields of medicinal chemistry and pharmacotherapeutics. The invention provides application of the compound shown in the formula I or pharmaceutically acceptable salt thereof in preparing drugs for antioxidation related diseases, especially theapplication in preparing anti-inflammatory drugs or antioxidant drugs. (The formula is shown in the description.).

Bifendate derivatives, preparation method and its in the treatment of autoimmune diseases

The invention belongs to the chemical medicine technical field, and especially relates to a bifendate derivative, a preparation method and an application of the bifendate derivative for treating autoimmune disease. A structure of the bifendate derivative